ARMP Return on Tangible Equity | ARMATA PHARMACEUTICALS, INC.

ARMATA PHARMACEUTICALS, INC. (ARMP) Return on Tangible Equity

2026-06-30: Return Tang Equity 81.81%.
2026-03-31: Return Tang Equity 89.63%.
2025-12-31: Return Tang Equity 78.17%.
2025-09-30: Return Tang Equity 47.22%.

Complete source-backed return tang equity history.

Available history: 2013-12-31 to 2026-06-30
Data captured: 2026-09-04

Historical Return Tang Equity

Date	Return Tang Equity
2026-06-30	81.81%
2026-03-31	89.63%
2025-12-31	78.17%
2025-09-30	47.22%
2025-06-30	35.10%
2025-03-31	0.74%
2024-12-31	36.55%
2024-09-30	75.62%
2024-06-30	134.55%
2024-03-31	132.10%
2023-12-31	192.90%
2023-09-30	369.32%
2023-06-30	-239.80%
2023-03-31	-227.75%
2022-12-31	-114.11%
2022-09-30	-78.02%
2022-06-30	-59.43%
2022-03-31	-45.72%
2021-12-31	-106.86%
2021-09-30	-118.50%
2021-06-30	-96.75%
2021-03-31	-74.62%
2020-12-31	-146.61%
2020-09-30	-96.42%
2020-06-30	-82.32%
2020-03-31	-69.97%
2019-12-31	-179.28%
2019-09-30	-111.04%
2019-06-30	-62.49%
2019-03-31	280.31%
2018-12-31	9002.65%
2018-09-30	-1164.53%
2018-06-30	-252.46%
2018-03-31	-185.08%
2017-12-31	-77.78%
2017-09-30	-1045.84%
2017-06-30	-1075.34%
2017-03-31	1564.06%
2016-12-31	-1016.07%
2016-09-30	-111.77%
2016-06-30	-27.61%
2016-03-31	1081.09%
2015-12-31	-10.72%
2015-09-30	13.55%
2015-06-30	325.19%
2015-03-31	-181.00%
2014-12-31	-514.22%
2014-09-30	249.99%
2014-06-30	356.44%
2014-03-31	235.78%
2013-12-31	213.94%

Annual Return Tang Equity

Date	Return Tang Equity
2025-12-31	78.17%
2024-12-31	36.55%
2023-12-31	192.86%
2022-12-31	-114.14%
2021-12-31	-106.89%
2020-12-31	-146.68%
2019-12-31	-179.40%
2018-12-31	14780.53%
2017-12-31	-77.78%
2016-12-31	-1016.07%
2015-12-31	-10.72%
2014-12-31	-514.22%
2013-12-31	213.94%

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
Neumora Therapeutics, Inc. (NMRA)	United States	$0.132B	-1.48
Caribou Biosciences, Inc. (CRBU)	United States	$0.134B	-1.79
enGene Therapeutics Inc. (ENGN)		$0.129B	-0.92
Tenaya Therapeutics, Inc. (TNYA)	United States	$0.140B	-1.60
LENZ Therapeutics, Inc. (LENZ)	United States	$0.117B	-1.41
Humacyte, Inc. (HUMA)	United States	$0.155B	-2.26
Black Diamond Therapeutics, Inc. (BDTX)	United States	$0.109B	-2.48
Outlook Therapeutics, Inc. (OTLK)	United States	$0.162B	-4.90
Acumen Pharmaceuticals, Inc. (ABOS)	United States	$0.162B	-1.83
Cardiff Oncology, Inc. (CRDF)	United States	$0.101B	-2.22